Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04862858
Status:
UNKNOWN
Last Update Posted:
2022-05-20
First Post:
2021-04-12
Brief Title:
Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes
Sponsor:
Humana Inc
Organization:
Humana Inc
Study Overview
Official Title:
Improving Outcomes in Patients With Comorbid T2DM and ASCVD Population Health Management Interventions Supporting Guideline-recommended SGLT2i and GLP-1 RA Medications
Status:
UNKNOWN
Status Verified Date:
2022-05
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an educational outreach to patients with type 2 diabetes mellitus T2DM and atherosclerotic cardiovascular disease ASCVD and their primary care and specialist providers to improve use of guideline-recommended treatments specifically sodium-glucose cotransporter 2 inhibitor SGLT2i and glucagon-like peptide-1 receptor agonist GLP-1 RA medications
Detailed Description:
Patients with type 2 diabetes mellitus a history of atherosclerotic cardiovascular disease without use of select guideline-recommended medications in the previous year will be identified from administrative claims Primary care providers will be identified randomly selected and randomized to the intervention arm or control arm All eligible patients for that provider will be included The patients specialist providers cardiologist andor endocrinologist as applicable will be identified and contacted The intervention will include a multi-faceted strategy to support providers in the care of their patients by sharing recent guideline-based treatment recommendations and provide patients with information regarding ways to reduce their cardiovascular risk Outreach will occur for all patients and providers randomized for the intervention - there will be no active enrollment or recruitment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None